Genome-wide methylation profiles in coronary artery ectasia

Area of Science:

• Cardiovascular Biology
• Epigenetics
• Molecular Medicine

Background:

• Coronary artery ectasia (CAE) is characterized by abnormal coronary artery dilation.
• The underlying mechanisms and effective treatments for CAE remain largely unknown.
• Prior research suggests a link between CAE risk factors and alterations in DNA methylation patterns.

Purpose of the Study:

• To conduct a systematic investigation of genome-wide methylation profiles in patients with coronary artery ectasia.
• To identify specific genes with differential methylation associated with CAE.
• To explore the functional implications of these methylation changes in CAE pathogenesis.

Main Methods:

• Genome-wide microarray analysis comparing DNA methylation profiles in 12 CAE patients and 12 matched controls.
• Statistical analysis (Wilcoxon's rank sum test) to identify differentially methylated genes (P<0.05, Δβ > |0.1|).
• Functional enrichment analysis (DAVID, GSEA) and pyro-sequencing validation in independent cohorts.

Main Results:

• Identified 89 genes with significantly different methylation levels between CAE patients and controls.
• Functional analysis revealed enrichment of immune and inflammatory response pathways.
• Validated significant methylation differences in TLR6 and NOTCH4, with lower TLR6 protein levels observed in CAE patients.

Conclusions:

• Genome-wide methylation profiling reveals significant alterations in CAE.
• TLR6 and NOTCH4 are key genes with differential methylation and expression in CAE.
• Further research into the roles of TLR6 methylation and expression is warranted for understanding and treating CAE.